0

Journal Articles

in Osteoporosis/Metabolic Bone Disease
 21-40 of 54 Articles
Editorial |  May 04, 2005
Bone Density and the Risk of Fractures:  Should Treatment Thresholds Vary by Race?
Louise S. Acheson, MD, MS
JAMA. 2005;293(17):2151-2154. doi:10.1001/jama.293.17.2151.
Original Contribution |  May 04, 2005 FREE
Bone Mineral Density and the Risk of Incident Nonspinal Fractures in Black and White Women
Jane A. Cauley, DrPH; Li-Yung Lui, MA, MS; Kristine E. Ensrud, MD, MPH; et al.
JAMA. 2005;293(17):2102-2108. doi:10.1001/jama.293.17.2102.
The Rational Clinical Examination |  December 15, 2004
Does This Woman Have Osteoporosis?
Amanda D. Green, MD; Cathleen S. Colón-Emeric, MD, MHSc; Lori Bastian, MD, MPH; et al.
JAMA. 2004;292(23):2890-2900. doi:10.1001/jama.292.23.2890.
INCLUDES: CME
Original Contribution |  November 03, 2004 FREE
Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes
John P. A. Ioannidis, MD; Stuart H. Ralston, MD; Simon T. Bennett, PhD; et al.
JAMA. 2004;292(17):2105-2114. doi:10.1001/jama.292.17.2105.
Medical News and Perspectives |  February 18, 2004
Experts Urge Early Investment in Bone Health
JAMA. 2004;291(7):811-812. doi:10.1001/jama.291.7.811.
Original Contribution |  October 01, 2003 FREE
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density:  The Women's Health Initiative Randomized Trial
Jane A. Cauley, DrPH; John Robbins, MD; Zhao Chen, PhD; et al.
JAMA. 2003;290(13):1729-1738. doi:10.1001/jama.290.13.1729.
Original Contribution |  August 27, 2003 FREE
Ultralow-Dose Micronized 17β-Estradiol and Bone Density and Bone Metabolism in Older Women:  A Randomized Controlled Trial
Karen M. Prestwood, MD; Anne M. Kenny, MD; Alison Kleppinger, MS; et al.
JAMA. 2003;290(8):1042-1048. doi:10.1001/jama.290.8.1042.
Original Contribution |  May 21, 2003 FREE
Combination Therapy With Hormone Replacement and Alendronate for Prevention of Bone Loss in Elderly Women:  A Randomized Controlled Trial
Susan L. Greenspan, MD; Neil M. Resnick, MD; Robert A. Parker, ScD
JAMA. 2003;289(19):2525-2533. doi:10.1001/jama.289.19.2525.
Medical News and Perspectives |  February 05, 2003
FDA Orders Estrogen Safety Warnings
JAMA. 2003;289(5):537-538. doi:10.1001/jama.289.5.537.
Scientific Review and Clinical Applications |  October 16, 2002 FREE
Clinical Use of Bone Densitometry:  Clinical Applications
David W. Bates, MD, MSc; Dennis M. Black, PhD; Steven R. Cummings, MD
JAMA. 2002;288(15):1898-1900. doi:10.1001/jama.288.15.1898.
Scientific Review and Clinical Applications |  October 16, 2002 FREE
Clinical Use of Bone Densitometry:  Scientific Review
Steven R. Cummings, MD; David Bates, MD, MSc; Dennis M. Black, PhD
JAMA. 2002;288(15):1889-1897. doi:10.1001/jama.288.15.1889.
From the Food and Drug Administration |  October 02, 2002
Device for Young Diabetics
JAMA. 2002;288(13):1579. doi:10.1001/jama.288.13.1579.
Scientific Review and Clinical Applications |  August 21, 2002 FREE
Postmenopausal Hormone Replacement Therapy:  Scientific Review
Heidi D. Nelson, MD, MPH; Linda L. Humphrey, MD, MPH; Peggy Nygren, MA; et al.
JAMA. 2002;288(7):872-881. doi:10.1001/jama.288.7.872.
Original Contribution |  May 22, 2002 FREE
Effect of Lower Doses of Conjugated Equine Estrogens With and Without Medroxyprogesterone Acetate on Bone in Early Postmenopausal Women
Robert Lindsay, MBChB, PhD, FRCP; J. Christopher Gallagher, MD; Michael Kleerekoper, MD; et al.
JAMA. 2002;287(20):2668-2676. doi:10.1001/jama.287.20.2668.
Medical News and Perspectives |  April 17, 2002
Hormone Replacement Therapy Falls Out of Favor With Expert Committee
JAMA. 2002;287(15):1923-1924. doi:10.1001/jama.287.15.1923.
Editorial |  December 12, 2001
Osteoporosis, an Underdiagnosed Disease
Charles H. Chesnut III, MD
JAMA. 2001;286(22):2865-2866. doi:10.1001/jama.286.22.2865.
Original Contribution |  December 12, 2001 FREE
Identification and Fracture Outcomes of Undiagnosed Low Bone Mineral Density in Postmenopausal Women:  Results From the National Osteoporosis Risk Assessment
Ethel S. Siris, MD; Paul D. Miller, MD; Elizabeth Barrett-Connor, MD; et al.
JAMA. 2001;286(22):2815-2822. doi:10.1001/jama.286.22.2815.
Clinical Investigation |  August 15, 2001 FREE
Bone Mineral Density Response to Estrogen Replacement in Frail Elderly Women:  A Randomized Controlled Trial
Dennis T. Villareal, MD; Ellen F. Binder, MD; Daniel B. Williams, MD; et al.
JAMA. 2001;286(7):815-820. doi:10.1001/jama.286.7.815.
Original Contribution |  July 04, 2001 FREE
Evaluation of Decision Rules for Referring Women for Bone Densitometry by Dual-Energy X-ray Absorptiometry
Suzanne M. Cadarette, MSc; Susan B. Jaglal, PhD; Timothy M. Murray, MD; et al.
JAMA. 2001;286(1):57-63. doi:10.1001/jama.286.1.57.
Original Contribution |  June 13, 2001 FREE
Association Between the T29→C Polymorphism in the Transforming Growth Factor β1 Gene and Breast Cancer Among Elderly White Women:  The Study of Osteoporotic Fractures
Elad Ziv, MD; Jane Cauley, DrPH; Phillip A. Morin, PhD; et al.
JAMA. 2001;285(22):2859-2863. doi:10.1001/jama.285.22.2859.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Ophthalmology
Small Case Series  |  Feb 2013
Squamous Metaplasia of the Conjunctiva:  A Previously Unrecognized Adverse Effect of Risedronate Sodium
Ivayla I. Geneva, BA; Ralph C. Eagle, MD; Ann Barker-Griffith, MD, FRCSC; et al.
JAMA Internal Medicine
Editor's Correspondence  |  Jan 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
Michael Pazianas, MD
JAMA Internal Medicine
Original Investigation  |  June 25, 2012
Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
Raphael P. H. Meier, MD; Thomas V. Perneger, MD; Richard Stern, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems